About this trial
The present study is a multicenter, randomized controlled clinical trial, which plans to enroll 450 diabetic patients aged more than 60 years. The participants will be randomly assigned in a 1:1 ratio and will receive either propofol or sevoflurane for intraoperative anesthesia maintenance to evaluate the impact of these two anesthetic drugs on postoperative delirium. The aim of our study is to explore whether the use of propofol for anesthesia maintenance in elderly diabetic patients undergoing elective non-cardiac major surgery can reduce the incidence of postoperative delirium. This study will provide new perspectives for improving perioperative management in elderly diabetic patients and optimizing anesthesia management strategies to reduce the risk of postoperative delirium.
Eligibility criteria
Qualifiers
Age ≥60 years
Elective surgery (with an expected duration of 2 hours or more)
ASA grade Ⅰ-Ⅲ
Voluntary participation and informed consent obtained
Disqualifiers
Pre-operative BMI≥35 kg/m² (Class II obesity or above)
Severe hepatic dysfunction (Child-Pugh class C) or pre-operative dialysis-dependent renal dysfunction
Known neurological or psychiatric diseases (Parkinson's disease, depression, schizophrenia), or cognitive impairment (dementia)
Severe visual or auditory impairments, language barriers, or patients who cannot cooperate
Trial design
Treatments tested in this trial
- TIVA ( anesthesia with propofol and remifentanil)
- VA(anesthesia with sevoflurane and remifentanil)